Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Price History  |  Ratios  |  Insiders

Bullboard - Stock Discussion Forum Cognition Therapeutics Inc CGTX

Cognition Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of small molecule therapeutics targeting age-related degenerative diseases and disorders of the central nervous system and retina. Its lead product candidate is CT1812, an orally delivered molecule modulator designed to penetrate the blood-brain barrier and bind selectively to the... see more

Bullboard (NDAQ:CGTX)

View:
User Avatar Image
(217)
•••
  • coolfooldumbguyX
Post by coolfooldumbguyon Aug 25, 2025 5:54am

Buy buddy buy.

Otherwise FOMO for you fellas out there today anyway so good luck to all of you guys
User Avatar Image
(217)
•••
  • coolfooldumbguyX
Post by coolfooldumbguyon Aug 13, 2025 8:15am

Using technical analysis for this stock.

It is signalling a big upswing for shareholders this morning so BUY it already or else FOMO
User Avatar Image
(27)
•••
  • ubiquitousmanX
Post by ubiquitousmanon May 20, 2023 1:40pm

Ok, I will start, stock closed at $2.17 5-19-23-could be ..

interesting. Different take on AD. High risk play but I could make a case for this to be a $50-$100 stock in 24 months if they can prove efficacy in AD treatment. Stay tuned. Minute market cap of ...more